Heron Therapeutics | HRTX - 债务

金融业

USD

USD 246.22M

现金及等价物

USD 26.12M

USD 11.12M

USD 228.98M

USD 90.52M

USD 149.65M

股息收益率

0

USD 38K

USD -3.88M

126

EPS每股收益

USD -0.02

股本和储备

USD 9.14M

USD 29.47M

债务利息支出

USD 600K

USD 433K

USD 140.64M

USD 129.1M

USD -2.95M

USD 40.55M

USD 38K

普通股股本

USD 188.31M

USD -2.95M

USD 40.59M

销售和管理费用

USD 23.74M

USD 54.57M

贸易债权人

USD 8.97M

应收帐款人

USD 89.59M

	债务	更改		日
ALKERMES	USD 1.58B		1.51B	2026-03
Alnylam Pharmaceuticals	USD 1.28B		30.06M	2025-12
Amarin	USD 0		0	2025-03
ANI Pharmaceuticals	USD 617.04M		3.28M	2025-12
Anika Therapeutics	USD 0		0	2025-03
Arrowhead Research	USD 312.77M		53.52M	2025-12
Eisai	JPY 236.67B		49.14B	2025-09
Emergent BioSolutions	USD 903.2M		495.2M	2023-06
Esperion Therapeutics	USD 262.92M		1.76M	2024-09
GlaxoSmithKline	GBP 19.06B		1.34B	2026-03
Heron Therapeutics	USD 149.65M		157K	2024-09
Insmed	USD 727.62M		275K	2026-03
Ligand Pharmaceuticals	USD 451.49M		494K	2025-12
Merck	USD 49.34B		7.97B	2025-12
Nektar Therapeutics	USD 0		0	2022-06
Neurocrine Biosciences	USD 406.2M		9.1M	2026-03
Omeros	USD 442.16M		199K	2023-09
Pacira	USD 367.66M		4.53M	2026-03
Regeneron Pharmaceuticals	USD 2.71B		300K	2026-03
Roche Holding	CHF 33.03B		1.41B	2025-06
Sangamo BioSciences	USD 0		0	2022-06
Surmodics	USD 29.55M		111K	2024-09
Ultragenyx Pharmaceutical	USD 36M		2.17M	2025-12
Veracyte	USD 39.65M		799K	2025-12
Vertex Pharmaceuticals	USD 1.99B		44M	2026-03